Literature DB >> 15120330

Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts.

Song Wan1, Sarah J George, Stuart A Nicklin, Anthony P C Yim, Andrew H Baker.   

Abstract

Patency rates for autologous saphenous vein (SV) conduits used in coronary artery bypass grafts remain poor. Patients with failed grafts are difficult to treat with subsequent interventions, necessitating the development of innovative therapies. Previous studies have suggested that induction of smooth muscle cell (SMC) apoptosis may reduce neointima formation. We overexpressed the proapoptotic gene p53 at the lumenal surface of SV grafts using adenoviral (Ad)-mediated gene transfer in porcine SVs prior to grafting in vivo and analyzed at 7 and 28 days (n = 6 and 7 per group, respectively). p53 overexpression induced a significant upregulation in apoptosis (4 +/- 0.6% for Adp53-infected grafts vs 0.6 +/- 0.1% for Adbeta-gal-infected grafts) and reduced neointimal proliferation by 28 +/- 1% at day 7 postinfection. Adp53-infected grafts had significantly greater lumenal areas than controls at both time points (4.8 +/- 0.6 mm2 vs 2.9 +/- 0.5 mm2 and 10.0 +/- 2.5 mm2 vs 4.2 +/- 1.2 mm2 at 7 and 28 days, respectively). Total graft areas were also increased at 28 days by p53, indicating positive vessel remodeling. Additionally, the thickening of the neointima was significantly reduced by 68 +/- 22% and 28 +/- 3% by p53 overexpression at day 7 and 28, respectively. Importantly, phenotypic changes were maintained at 3 months. Induction of SMC apoptosis by transient p53 overexpression positively influenced vein graft remodeling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120330     DOI: 10.1016/j.ymthe.2004.02.005

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  12 in total

Review 1.  Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

2.  Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62.

Authors:  Tang-Jun Ai; Jian-Yong Sun; Lin-Juan Du; Chaoji Shi; Chao Li; Xue-Nan Sun; Yan Liu; Lihui Li; Zhixiong Xia; Lijun Jia; Jianmiao Liu; Sheng-Zhong Duan
Journal:  Cell Death Differ       Date:  2017-10-13       Impact factor: 15.828

3.  Efficient gene transfer and durable transgene expression in grafted rabbit veins.

Authors:  Liang Du; Jingwan Zhang; Alexander W Clowes; David A Dichek
Journal:  Hum Gene Ther       Date:  2015-01       Impact factor: 5.695

Review 4.  Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.

Authors:  Akihito Muto; Lynn Model; Kenneth Ziegler; Sammy D D Eghbalieh; Alan Dardik
Journal:  Circ J       Date:  2010-07-01       Impact factor: 2.993

5.  Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.

Authors:  Dario F Riascos-Bernal; Prameladevi Chinnasamy; Jordana N Gross; Vanessa Almonte; Lander Egaña-Gorroño; Dippal Parikh; Smitha Jayakumar; Liang Guo; Nicholas E S Sibinga
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-16       Impact factor: 8.311

6.  In vivo modulation of Nogo-B attenuates neointima formation.

Authors:  Angelika B Kritz; Jun Yu; Paulette L Wright; Song Wan; Sarah J George; Crawford Halliday; Ning Kang; William C Sessa; Andrew H Baker
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

7.  Comparison of anticoagulant effects on vein grafts between human TFPI gene transfection and aspirin oral administration.

Authors:  Deguang Feng; Quan Li; Kailun Zhang; Xionggang Jiang; Song Leng; Heping Deng; Jian'e Feng; Tucheng Sun; Long Wu; Cheng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

Review 8.  Cardiovascular gene therapy: current status and therapeutic potential.

Authors:  M M Gaffney; S O Hynes; F Barry; T O'Brien
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

9.  Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.

Authors:  A L Parker; K M White; C A Lavery; J Custers; S N Waddington; A H Baker
Journal:  Gene Ther       Date:  2013-09-05       Impact factor: 5.250

10.  Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector.

Authors:  Lorraine M Work; Paul N Reynolds; Andrew H Baker
Journal:  Genet Vaccines Ther       Date:  2004-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.